Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylaxis vs On-Demand Kogenate FS in Adult Hemophilia A
NCT00586521Phase 4Completed
- Sponsor
- Bayer
- Start
- Feb 2006
- Primary completion
- Mar 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
Phase 4, open-label, single-arm trial of octocog alfa in hemophilia A, sponsored by Bayer. Primary endpoint: Number of Joint Bleeds. Started Feb 2006; status: completed.
02
Drugs
octocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00586521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00586521.